Correlation Between MedinCell and Adaptive Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MedinCell and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedinCell and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedinCell SA and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on MedinCell and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedinCell with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedinCell and Adaptive Biotechnologies.

Diversification Opportunities for MedinCell and Adaptive Biotechnologies

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between MedinCell and Adaptive is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding MedinCell SA and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and MedinCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedinCell SA are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of MedinCell i.e., MedinCell and Adaptive Biotechnologies go up and down completely randomly.

Pair Corralation between MedinCell and Adaptive Biotechnologies

If you would invest  558.00  in Adaptive Biotechnologies Corp on September 25, 2024 and sell it today you would earn a total of  81.00  from holding Adaptive Biotechnologies Corp or generate 14.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MedinCell SA  vs.  Adaptive Biotechnologies Corp

 Performance 
       Timeline  
MedinCell SA 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MedinCell SA are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain essential indicators, MedinCell reported solid returns over the last few months and may actually be approaching a breakup point.
Adaptive Biotechnologies 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Adaptive Biotechnologies Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Adaptive Biotechnologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

MedinCell and Adaptive Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MedinCell and Adaptive Biotechnologies

The main advantage of trading using opposite MedinCell and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedinCell position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.
The idea behind MedinCell SA and Adaptive Biotechnologies Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stocks Directory
Find actively traded stocks across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements